West Pharmaceutical Services, Inc. announced executive leadership changes as part of its succession planning process. Bernard J. Birkett, Senior Vice President and Chief Financial Officer, informed the company of his intention to retire from his position this year. West has initiated a search for his successor, with Mr. Birkett planning to remain as CFO until a successor is in place and then serve as an advisor to ensure a seamless transition.
Mr. Birkett joined West in June 2018 and was appointed to the combined role of Chief Financial and Operations Officer in 2022, before transitioning back to solely CFO responsibilities in April 2024. His contributions were noted as pivotal in strengthening West's financial and business profile, particularly in navigating the global pandemic, destocking challenges, and the emergence of GLP-1s.
Concurrently, Shane Campbell has been appointed Senior Vice President, Chief Proprietary Segment Officer, effective May 5, 2025. Mr. Campbell joins West from Carlisle Companies Inc., where he served as Chief Commercial Officer of the Construction Materials business. He brings extensive global management experience across operations, engineering, commercial, and strategy from a 20-year career at DuPont.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.